Search Results - "FILLINGER, Janos"
-
1
Current therapy of KRAS-mutant lung cancer
Published in Cancer and metastasis reviews (01-12-2020)“…KRAS mutations are the most frequent gain-of-function alterations in patients with lung adenocarcinoma (LADC) in the Western world. Although they have been…”
Get full text
Journal Article -
2
Proteomic Workflows for High-Quality Quantitative Proteome and Post-Translational Modification Analysis of Clinically Relevant Samples from Formalin-Fixed Paraffin-Embedded Archives
Published in Journal of proteome research (01-01-2021)“…Well-characterized archival formalin-fixed paraffin-embedded (FFPE) tissues are of much value for prospective biomarker discovery studies, and protocols that…”
Get full text
Journal Article -
3
Inter- and intratumoral proteomics and glycosaminoglycan characterization of ALK rearranged lung adenocarcinoma tissues: a pilot study
Published in Scientific reports (17-04-2023)“…Lung cancer is one of the most common types of cancer with limited therapeutic options, therefore a detailed understanding of the underlying molecular changes…”
Get full text
Journal Article -
4
A clonal expression biomarker associates with lung cancer mortality
Published in Nature medicine (01-10-2019)“…An aim of molecular biomarkers is to stratify patients with cancer into disease subtypes predictive of outcome, improving diagnostic precision beyond clinical…”
Get full text
Journal Article -
5
Spatially Resolved Proteomic and Transcriptomic Profiling of Anaplastic Lymphoma Kinase-Rearranged Pulmonary Adenocarcinomas Reveals Key Players in Inter- and Intratumoral Heterogeneity
Published in International journal of molecular sciences (01-07-2023)“…Pulmonary adenocarcinomas (pADCs) with an rearrangement are a rare cancer subtype, necessitating comprehensive molecular investigations to unravel their…”
Get full text
Journal Article -
6
Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients
Published in Journal of cancer research and clinical oncology (01-07-2018)“…Objectives While the predictive value of programmed cell death ligand-1 (PD-L1) protein expression for immune checkpoint inhibitor therapy of lung cancer has…”
Get full text
Journal Article -
7
Single-cell immunophenotyping revealed the association of CD4+ central and CD4+ effector memory T cells linking exacerbating chronic obstructive pulmonary disease and NSCLC
Published in Frontiers in immunology (2023)“…Tobacco smoking generates airway inflammation in chronic obstructive pulmonary disease (COPD), and its involvement in the development of lung cancer is still…”
Get full text
Journal Article -
8
Comparative expression analysis of immune-related markers in surgically resected lung neuroendocrine neoplasms
Published in Lung cancer (Amsterdam, Netherlands) (01-07-2023)“…•Atypical carcinoids are characterized by high tumor cell CD40 expression.•High CD70 and CD137 expression by tumor cells are characteristic for LCNEC.•SCLC has…”
Get full text
Journal Article -
9
Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms
Published in Cancer Immunology, Immunotherapy (02-05-2024)“…Background Advancements in immunotherapeutic approaches only had a modest impact on the therapy of lung neuroendocrine neoplasms (LNENs). Our multicenter study…”
Get full text
Journal Article -
10
Molecular profiles of small cell lung cancer subtypes: Therapeutic implications
Published in Molecular therapy. Oncolytics (26-03-2021)“…Small cell lung cancer (SCLC; accounting for approximately 13%–15% of all lung cancers) is an exceptionally lethal malignancy characterized by rapid doubling…”
Get full text
Journal Article -
11
Claudin expression in pulmonary adenoid cystic carcinoma and mucoepidermoid carcinoma
Published in Pathology oncology research (09-08-2023)“…Background: Although the expression of tight junction protein claudins (CLDNs) is well known in common histological subtypes of lung cancer, it has not been…”
Get full text
Journal Article -
12
Comparative analysis of prognostic histopathologic parameters in subtypes of epithelioid pleural mesothelioma
Published in Histopathology (01-07-2020)“…Aims Malignant pleural mesothelioma (MPM) is a rare malignancy with a dismal prognosis. While the epithelioid type is associated with a more favourable…”
Get full text
Journal Article -
13
Activated p53 in the anti-apoptotic milieu of tuberous sclerosis gene mutation induced diseases leads to cell death if thioredoxin reductase is inhibited
Published in Apoptosis (London) (01-06-2021)“…Tuberous sclerosis, angiomyolipoma and lymphangioleiomyomatosis are a group of diseases characterized by mutation in tuberous sclerosis genes (TSC 1-2). TSC…”
Get full text
Journal Article -
14
A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures
Published in NPJ precision oncology (18-06-2021)“…PARP inhibitors are approved for the treatment of solid tumor types that frequently harbor alterations in the key homologous recombination (HR) genes, BRCA1/2…”
Get full text
Journal Article -
15
PD-1 and PD-L1 expression in rare lung tumors
Published in Pathology oncology research (18-05-2023)“…Our knowledge is still limited about the characteristics and treatment of rare lung tumors. The aim of our study was to determine programmed cell death…”
Get full text
Journal Article -
16
C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer
Published in World journal of surgical oncology (19-02-2024)“…By being highly involved in the tumor evolution and disease progression of small cell lung cancer (SCLC), Myc family members (C-Myc, L-Myc, and N-Myc) might…”
Get full text
Journal Article -
17
The landscape of small cell lung cancer metastases: Organ specificity and timing
Published in Thoracic cancer (01-03-2021)“…Background Early metastasis is a hallmark of small cell lung cancer (SCLC). However, the mechanisms and resulting patterns of SCLC dissemination are unclear…”
Get full text
Journal Article -
18
Normalization of Enzyme Expression and Activity Regulating Vitamin A Metabolism Increases RAR-Beta Expression and Reduces Cellular Migration and Proliferation in Diseases Caused by Tuberous Sclerosis Gene Mutations
Published in Frontiers in oncology (11-06-2021)“…Mutation in a tuberous sclerosis gene (TSC1 or 2) leads to continuous activation of the mammalian target of rapamycin (mTOR). mTOR activation alters cellular…”
Get full text
Journal Article -
19
Lymphangiogenesis Correlates with Lymph Node Metastasis, Prognosis, and Angiogenic Phenotype in Human Non–Small Cell Lung Cancer
Published in Clinical cancer research (15-10-2005)“…Purpose: Recent experimental studies have revealed that lymphangiogenesis plays an important role in cancer progression, but its clinical significance in the…”
Get full text
Journal Article -
20
Comparison of Predictive Immunohistochemical Marker Expression of Primary Breast Cancer and Paired Distant Metastasis using Surgical Material: A Practice-Based Study
Published in The journal of histochemistry and cytochemistry (01-04-2016)“…Parallel studies of primary breast carcinomas and corresponding distant metastases samples reveal considerable differences. Our aim was to highlight this issue…”
Get full text
Journal Article